Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens

被引:0
作者
Djordjevic, D
Nikolic, J
Stefanovic, V
机构
[1] Univ Nish, Sch Med, Inst Nephrol & Hemodialysis, YU-18000 Nish, Yugoslavia
[2] Univ Nish, Sch Med, Dept Neonatol, YU-18000 Nish, Yugoslavia
[3] Univ Nish, Sch Med, Inst Biochem, YU-18000 Nish, Yugoslavia
来源
PATHOLOGIE BIOLOGIE | 1998年 / 46卷 / 10期
关键词
ethanol; enzyme induction; drug interactions; toxic agent interactions;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Chronic ethanol abuse is associated with increased activity of the microsomal ethanol-oxidizing system. This effect is due primarily to induction by ethanol of a specific cytochrome P450 (CYP2E1) responsible for enhanced oxidation of ethanol and other P450 substrates and consequently, for metabolic tolerance to these substances. Furthermore, cytochrome 450 induction increases the activation of numerous xenobiotics to toxic metabolites and of chemical carcinogens to reactive metabolites, thereby accelerating their adverse effects. Microsomal enzyme induction has been associated with increased reactive oxygen species production and enhanced lipid peroxidation, as well as with decreased enzymatic and nonenzymatic scavenger activity, providing another possible explanation for ethanol-mediated toxicity. Yet another effect of chronic alcohol abuse is chronic immune system activation, which is the mechanism underlying alcohol-related liver disease. The metabolism of steroids and vitamins is catalyzed by P350 and is altered in chronic alcoholics. This article reviews recent advances in the understanding of ethanol interactions with drugs, toxic agents, and carcinogens, as well as with steroids and vitamins.
引用
收藏
页码:760 / 770
页数:11
相关论文
共 50 条
  • [31] Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications
    Zhang, Yan-Yan
    Yang, Ling
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (06) : 621 - 629
  • [32] Automated Information Extraction and Structure-Activity Relationship Analysis of Cytochrome P450 Substrates
    Yamashita, Fumiyoshi
    Feng, Chunlai
    Yoshida, Shuya
    Itoh, Takayuki
    Hashida, Mitsuru
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (02) : 378 - 385
  • [33] CYTOCHROME-P450 MONOOXYGENASES AND INTERACTIONS OF PSYCHOTROPIC-DRUGS - A 5-YEAR UPDATE
    SHEN, WW
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 1995, 25 (03) : 277 - 290
  • [34] Alcohol-associated rhabdomyolysis: Ethanol induction of cytochrome P450 may potentiate myotoxicity
    Riggs, JE
    CLINICAL NEUROPHARMACOLOGY, 1998, 21 (06) : 363 - 364
  • [35] Up-regulation of cytochrome P450 and phase II enzymes by xenobiotics in precision-cut tissue slices
    Ioannides, Costas
    XENOBIOTICA, 2013, 43 (01) : 15 - 28
  • [36] From electrochemistry to enzyme kinetics of cytochrome P450
    Shumyantseva, Victoria V.
    Kuzikov, Alexey V.
    Masamrekh, Rami A.
    Bulko, Tatiana V.
    Archakov, Alexander I.
    BIOSENSORS & BIOELECTRONICS, 2018, 121 : 192 - 204
  • [37] Cytochrome P450 in Palliative Care and Hospice Kits
    Quinn, Mary Jo
    JOURNAL OF HOSPICE & PALLIATIVE NURSING, 2019, 21 (04) : 280 - 285
  • [38] Effects of icaritin on cytochrome P450 enzymes in rats
    Liang, Dong-Lou
    Zheng, Shuang-li
    PHARMAZIE, 2014, 69 (04): : 301 - 305
  • [39] Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin
    Li, AP
    Reith, MK
    Rasmussen, A
    Gorski, JC
    Hall, SD
    Xu, L
    Kaminski, DL
    Cheng, LK
    CHEMICO-BIOLOGICAL INTERACTIONS, 1997, 107 (1-2) : 17 - 30
  • [40] In vitro inhibition of human cytochrome P450 by cudratricusxanthone A
    Sim, Juhee
    Choi, Eunhwa
    Lee, You-Mie
    Jeong, Gil-Saeng
    Lee, Sangkyu
    FOOD AND CHEMICAL TOXICOLOGY, 2015, 81 : 171 - 175